AzTrials
AzTrials

Sedentary LifestyleNCT03513380

Can Gaming Get You Fit? A High-Intensity Exergaming Intervention in Adults

A study testing Exergaming in people with Sedentary Lifestyle, run by Norwegian University of Science and Technology at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this project is to assess if playing a newly developed videogame that require physical activity (e.g. exergame) can lead to health benefits. The project will include 50 adult participants that are not particularly physically active. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Sedentary Lifestyle
What is being tested?
Exergaming
Could I receive a placebo?
No, everyone receives an active treatment
How many people
52 participants
Where
1 siteNorway
Study dates
25 May 2018to 30 Nov 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Sedentary (<150 mins of moderate intensity physical activity/week)
  • Able to ride a bike for up to 60 minutes

Who cannot join

  • Known cardiovascular disease
  • Taking beta-blockers or anti-arrhythmic drugs

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Department of Circulation and Medical Imaging

    Trondheim, 7491

Other trials in Norway

About this study

Official title: Motivational High Intensity Training Through a Cutting-edge Gaming Platform. A Randomised, Controlled Trial

The purpose of this project is to assess if playing a newly developed videogame that require physical activity (e.g. exergame) can lead to health benefits. The project will include 50 adult participants that are not particularly physically active. They will be randomized into two groups where one group will be given free access to the exergame for 6 months. The physical fitness (maximal oxygen consumption), blood markers of cardiometabolic health and body composition of the subjects will be tested before, mid-ways and after the intervention period. Also, the participants gaming frequency will be registered throughout the 6-month period. Aim of this study is to investigate if access to this game can provide health benefits for individuals who are not motivated to take part in regular physical activity.

Being tested
Exergaming
Keywords
Exercise therapy, Physical fitness, Gaming, Adult, Healthy lifestyle, Fitness testing
Medical subject headings
Sedentary Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExergamingBehavioural

    Also called PlayPulse, PedalTanks

    free access to the exergame PedalTanks during 6 months

Study groups in NCT03513380
Study groupRoleWhat they receive
ExergamingExperimentalfree access to the exergame PedalTanks
Receives: Behavioral: Exergaming
ControlNo interventionrecommended to continue with their normal daily routine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. VO2max (Maximal Aerobic Capacity)

    Measured: 3 months

  2. VO2max (Maximal Aerobic Capacity)

    Measured: 6 months

Secondary outcomes (13)
  1. Daily average energy expenditure

    Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.

    Measured: 3 and 6 months

  2. Daily average number of steps

    Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.

    Measured: 3 and 6 months

  3. Daily time in sedentary activity (< 3.0 metabolic equivalents = METs)

    Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.

    Measured: 3 and 6 months

  4. Daily time in moderate intensity activity (3.0-6.0 metabolic equivalents = METs)

    Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.

    Measured: 3 and 6 months

  5. Daily time in vigorous intensity activity (6.0-9.0 metabolic equivalents = METs)

    Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.

    Measured: 3 and 6 months

  6. Daily time in very vigorous intensity activity (>9.0 metabolic equivalents = METs)

    Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.

    Measured: 3 and 6 months

  7. Daily average total physical activity duration

    Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.

    Measured: 3 and 6 months

  8. Bioelectrical impedance

    Body composition assessed using bioelectrical impedance analysis (InBody 720)

    Measured: 3 and 6 months

  9. Blood Pressure

    Measured: 3 and 6 months

  10. Fasting circulating glucose, as blood marker of cardiometabolic health

    Measured: 6 months

  11. Lipid profile, as blood marker of cardiometabolic health

    Measured: 6 months

  12. Circulating insulin concentration, as blood marker of cardiometabolic health

    Measured: 6 months

  13. glucose response to a 2 hour glucose tolerance test, as blood marker of cardiometabolic health

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 May 2018
  2. Study start25 May 2018
  3. Primary completion30 Nov 2019
  4. Study completion30 Nov 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
52 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03513380
Sponsor's protocol ID
2017/1501
Status last verified
Dec 2019
First submitted
5 Apr 2018
Last updated
11 Dec 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Berg J, Wang AI, Lydersen S, Moholdt T. Can Gaming Get You Fit? Front Physiol. 2020 Aug 20;11:1017. doi: 10.3389/fphys.2020.01017. eCollection 2020.

    PubMed 32973553

Questions about this trial

What is this clinical trial studying?

A study testing Exergaming in people with Sedentary Lifestyle, run by Norwegian University of Science and Technology at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Dec 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

VO2max (Maximal Aerobic Capacity) (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03513380, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in